Cytosorbents Corporation
CTSONASDAQHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $16.55M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.41$12.10
- Volume (live)
- -
- Avg. volume (3M)
- 47.64K
Cytosorbents (CTSO) Stock Price & Financial Analysis
Cytosorbents Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $5.22 - $5.96 |
|---|---|
| 52-Week High | $12.10 |
| 52-Week Low | $0.41 |
| Open | $5.90 |
| Volume (last close) | 43.05K |
| Average Volume (3M) | 47.64K |
| Revenue (TTM) | 37.22M |
|---|---|
| Net Income (TTM) | -18.21M |
| Free Cash Flow (TTM) | -9.59M |
| EPS (TTM) | −$5.80 |
| Profit Margin | -48.94% |
| Operating Margin | -32.64% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 16.55M |
|---|---|
| Shares Outstanding | 3.14M |
| Price to Sales (P/S) | 0.44 |
| Price to Book (P/B) | -22.04 |
| EV/EBITDA | -2.27 |
| 50-Day MA | $5.65 |
|---|---|
| 200-Day MA | $3.44 |
| 1-Year Change | +613.78% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Cytosorbents at a Glance
As of the Oct 23, 2026 close, Cytosorbents (CTSO) has a market capitalization of $16.55M. The stock trades at 0.4× sales. Over the trailing twelve months it lost $18.21M on revenue of $37.22M and burned $9.59M of free cash flow. Revenue grew 1.6% year over year.
As of its latest reported balance sheet, it holds $4.41M in cash and securities against $17.24M of debt, a net debt position of $12.83M.
Cytosorbents does not currently pay a dividend.
The share price is up 613.8% over the past year. At $5.27 (the Oct 23, 2026 close) it sits within its 52-week range of $0.41 to $12.10, above its 200-day moving average of $3.44.
Frequently Asked Questions About Cytosorbents
What is the current stock price for CTSO?
As of the Oct 23, 2026 close, CTSO stock trades at $5.27. The 52-week range is $0.41–$12.10, with a day range of $5.22–$5.96.
What is the P/E ratio for CTSO?
The P/E ratio (Price-to-Earnings) for CTSO is shown in the Key Statistics section. This valuation metric helps compare Cytosorbents Corporation to industry peers.
Does CTSO pay dividends?
Cytosorbents does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CTSO?
Analyst ratings and recommendations for CTSO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CTSO?
As of the Oct 23, 2026 close, Cytosorbents's market capitalization is $16.5M, classifying it as a micro-cap company. Cytosorbents operates in the Healthcare sector within the Medical Devices industry.